 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

PMV Pharmaceuticals reports Q3 EPS (34c), consensus (45c)

Updated data from Phase 1 PYNNACLE clinical trial of PC14586 presented at 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics demonstrated responses across...

PMV Pharmaceuticals Reports Third Quarter 2023 Financial Results and Corporate Highlights

PMV Pharmaceuticals (NASDAQ:PMVP  Free Report) had its price objective decreased by HC Wainwright from $29.00 to $5.00 in a research note issued to investors on Monday, Benzinga reports. HC...

HC Wainwright Trims PMV Pharmaceuticals (NASDAQ:PMVP) Target Price to $5.00

PMV Pharmaceuticals price target lowered to $5 from $29 at H.C. Wainwright

PMV Pharmaceuticals' PC14586 Phase 1 data demonstrates anti-tumor activity

Updated PC14586 Phase 1 data presented today as a late-breaking poster at 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer TherapeuticsConfirmed responses observed in...

PMV Pharmaceuticals Updated PC14586 Phase 1 Data Demonstrated Anti-Tumor Activity Across Multiple Solid Tumor Types With a TP53 Y220C Mutation

This indicator may be signaling that PMVP's price has further to drop, since it moved below its price 14 days ago. Traders may consider selling the stock, shorting the stock, or exploring put options...

PMV Pharmaceuticals (PMVP, $4.75) entered Downtrend as Momentum indicator drops below 0 level on Oct 11, 2023

This is a signal that PMVP's price could be shifting from a downtrend to an uptrend. Traders may consider buying the stock or exploring call options...

PMV Pharmaceuticals (PMVP, $4.75) RSI Indicator left the oversold zone on October 11, 2023

For the last three days, A.I.dvisor has detected that PMVP's AroonDown red line is above 70 while the AroonUp green line is below 30 for three straight days. This move could indicate a strong...

PMV Pharmaceuticals (PMVP, $4.75) Aroon Indicator entered a Downtrend on October 11, 2023.

PMV Pharmaceuticals (PMVP, $6.42) Aroon Indicator entered a Downtrend on October 10, 2023.

PMV Pharmaceuticals, Inc. is a precision oncology company, which engages in the discovery and development of small molecule, tumor-agnostic therapies targeting p53. The company was founded by Arnold J. Levine, David Henry Mac, and Thomas E. Shenk in March 2013 and is headquartered in Princeton, NJ.

Market Cap	$117.66M
Volume (M)	311,840.00
52-Wk High	$10.22
52-Wk Low	$1.18

PMVP PMV Pharmaceuticals Inc

About

Feed

News

Sentiment

Earnings

Fundamentals